Overview

EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)

Status:
Terminated
Trial end date:
2017-02-27
Target enrollment:
Participant gender:
Summary
EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Epoetin Alfa